title: Images in cardiovascular medicine. Severe endothelial dysfunction after sirolimus-eluting stent implantation.
authors.affiliation: Cardiovascular Medicine, Okayama Red Cross General Hospital, Okayama, Japan. maekawa@okayama-med.jrc.or.jp
authors.forename: Kiyoaki
authors.initials: K
authors.lastname: Maekawa
authors.forename: Kenji
authors.initials: K
authors.lastname: Kawamoto
authors.forename: Soichiro
authors.initials: S
authors.lastname: Fuke
authors.forename: Ryo
authors.initials: R
authors.lastname: Yoshioka
authors.forename: Hironori
authors.initials: H
authors.lastname: Saito
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Sato
authors.forename: Toru
authors.initials: T
authors.lastname: Hioka
mesh_terms: D000109:Acetylcholine / Q000008:administration & dosage / Q000494:pharmacology; D000328:Adult; D017023:Coronary Angiography; D023921:Coronary Stenosis / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy; D003329:Coronary Vasospasm / Q000139:chemically induced / Q000188:drug therapy; D003331:Coronary Vessels / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D004343:Drug Implants; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D009203:Myocardial Infarction / Q000209:etiology / Q000628:therapy*; D005996:Nitroglycerin / Q000627:therapeutic use; D020123:Sirolimus / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D015607:Stents; D014661:Vasoconstriction / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D004343:Drug Implants; D014662:Vasoconstrictor Agents; D005996:Nitroglycerin; D000109:Acetylcholine; D020123:Sirolimus